Global Cell Therapy Manufacturing Market, By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies), By Source of Cell (Autologous v/s Allogenic), By Scale of Operation (Preclinical, Clinical, Commercial), By Source (In-House v/s Contract Manufacturing), By Application (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), By Region, Competition Forecast and Opportunities, 2026

January 2022 | 329 pages | ID: G87861374649EN
TechSci Research

Abstracts

Global cell therapy manufacturing market was valued at USD3123.44 million in the year 2020 and is anticipated to grow with a CAGR value of 12.0% in the forecast period, 2022-2026 to reach market value of USD6015.09 million by 2026F. The market growth can be attributed to advancing biopharmaceutical industries across the globe. Moreover, increasing dependency on cell therapy and thus therapeutics & pharmaceutical products for the efficient treatment of the patients suffering from critical diseases and conditions is also supporting the growth of the global cell therapy manufacturing market in the next five years. Additionally, growing prevalence of chronic diseases like cardiovascular diseases, cancer disease, along with lifestyle diseases like obesity, diabetes that further deteriorates immunity of the humans further contributes to the growth of the global cell therapy manufacturing market in the future five years. Recent instance of COVID-19 outbreak that caused millions of deaths worldwide has created a demand for advanced cell therapy manufacturing to devise pharmaceuticals, vaccines, etc. Significant development and advancement in cell-based therapies for skin rejuvenation and tendon regeneration are further driving the growth of the global cell therapy manufacturing market in the forecast period.

The global cell therapy manufacturing market is segmented by therapy, source of cell, scale of operation, source, application, end user, company, and regional distribution. Based on application, the market is further divided into oncology, cardiovascular diseases, orthopedic diseases, and others. Oncology sub-segment is anticipated to hold more than 50% of the revenue shares of the market and dominate the application based market segmentation in the upcoming five years. The growth can be attributed to increasing instances of various types of cancer in the global population. Moreover, increased technological advancement and consistent cell therapy based research for the treatment of cancer is further anticipated to support the market growth.

Novartis AG, F. Hoffmann-La Roche AG, Gilead Sciences, Inc., Thermo Fischer Scientific, Inc., Catalent, Inc., JSR Life Sciences LLC (KBI Biopharma Inc), Waisman Center (Waisman Biomanufacturing), Cell and Gene Therapy Catapult, Merck KGaA, Lonza Group, Oxford Biomedica Plc, WuXi AppTec, Charles River Laboratoires International Inc., Institut Merieux (ABL Inc.), BioCentriq, Centre for Commercialization of Regenerative Medicine (CCRM), Fujifilm Holdings Corporation (Fujifilm Cellular Dynamics), Amgen Inc., Bluebird Bio Inc., Takeda Pharmaceutical Company Limited are among the major market players in the global platform that lead the market growth of the global cell therapy manufacturing market.

Years considered for this report:

• Historical Years: 2016-2019
• Base Year: 2020
• Estimated Year: 2021
• Forecast Period: 2022–2026

Objective of the Study:

• To analyze and estimate the market size of global cell therapy manufacturing market from 2016 to 2020.
• To estimate and forecast the market size of global cell therapy manufacturing market from 2021 to 2026 and growth rate until 2026.
• To classify and forecast global cell therapy manufacturing market based on therapy, source of cell, scale of operation, source, application, end user, company, and regional distribution.
• To identify dominant region or segment in the global cell therapy manufacturing market.
• To identify drivers and challenges for global cell therapy manufacturing market.
• To examine competitive developments such as expansions, mergers & acquisitions, etc., in global cell therapy manufacturing market.
• To identify and analyze the profile of leading players operating in global cell therapy manufacturing market.
• To identify key sustainable strategies adopted by market players in global cell therapy manufacturing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the companies, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global cell therapy manufacturing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• Companies, and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to cell therapy manufacturing
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global cell therapy manufacturing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Global Cell Therapy Manufacturing Market, By Therapy:
• T-Cell Therapies
• Dendritic Cell Therapies
• Tumor Cell Therapies
• Stem Cell Therapies
• Global Cell Therapy Manufacturing Market, By Source of Cell:
• Autologous
• Allogenic
• Global Cell Therapy Manufacturing Market, By Scale of Operation:
• Preclinical
• Clinical
• Commercial
• Global Cell Therapy Manufacturing Market, By Source:
• In-House
• Contract Manufacturing
• Global Cell Therapy Manufacturing Market, By Application:
• Oncology
• Cardiovascular Diseases
• Orthopedic Diseases
• Others
• Global Cell Therapy Manufacturing Market, By End User:
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others
• Global Cell Therapy Manufacturing Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• France
• United Kingdom
• Spain
• Italy
• Asia-Pacific
• China
• Japan
• South Korea
• Australia
• India
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• Israel
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global cell therapy manufacturing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. IMPACT OF COVID-19 ON GLOBAL CELL THERAPY MANUFACTURING MARKET

5. VOICE OF CUSTOMERS

5.1. Brand Awareness
5.2. Commonly Used Cell Therapies
5.3. Preferences Based on Source of Cell Among Medical Professionals

6. GLOBAL CELL THERAPY MANUFACTURING MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies)
  6.2.2. By Source of Cell (Autologous v/s Allogenic)
  6.2.3. By Scale of Operation (Preclinical, Clinical, Commercial)
  6.2.4. By Source (In-House v/s Contract Manufacturing)
  6.2.5. By Application (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Others)
  6.2.6. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)
  6.2.7. By Company (2020)
  6.2.8. By Region
6.3. Product Market Map
  6.3.1. By Therapy
  6.3.2. By Scale of Operation
  6.3.3. By Source
  6.3.4. By Application
  6.3.5. By Region

7. NORTH AMERICA CELL THERAPY MANUFACTURING MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Therapy
  7.2.2. By Source of Cell
  7.2.3. By Scale of Operation
  7.2.4. By Source
  7.2.5. By Application
  7.2.6. By End User
  7.2.7. By Country
7.3. North America: Country Analysis
  7.3.1. United States Cell Therapy Manufacturing Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Therapy
      7.3.1.2.2. By Source of Cell
      7.3.1.2.3. By Scale of Operation
      7.3.1.2.4. By Source
      7.3.1.2.5. By Application
      7.3.1.2.6. By End User
  7.3.2. Canada Cell Therapy Manufacturing Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Therapy
      7.3.2.2.2. By Source of Cell
      7.3.2.2.3. By Scale of Operation
      7.3.2.2.4. By Source
      7.3.2.2.5. By Application
      7.3.2.2.6. By End User
  7.3.3. Mexico Cell Therapy Manufacturing Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Therapy
      7.3.3.2.2. By Source of Cell
      7.3.3.2.3. By Scale of Operation
      7.3.3.2.4. By Source
      7.3.3.2.5. By Application
      7.3.3.2.6. By End User

8. EUROPE CELL THERAPY MANUFACTURING MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Therapy
  8.2.2. By Source of Cell
  8.2.3. By Scale of Operation
  8.2.4. By Source
  8.2.5. By Application
  8.2.6. By End User
  8.2.7. By Country
8.3. Europe: Country Analysis
  8.3.1. Germany Cell Therapy Manufacturing Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Therapy
      8.3.1.2.2. By Source of Cell
      8.3.1.2.3. By Scale of Operation
      8.3.1.2.4. By Source
      8.3.1.2.5. By Application
      8.3.1.2.6. By End User
  8.3.2. France Cell Therapy Manufacturing Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Therapy
      8.3.2.2.2. By Source of Cell
      8.3.2.2.3. By Scale of Operation
      8.3.2.2.4. By Source
      8.3.2.2.5. By Application
      8.3.2.2.6. By End User
  8.3.3. United Kingdom Cell Therapy Manufacturing Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Therapy
      8.3.3.2.2. By Source of Cell
      8.3.3.2.3. By Scale of Operation
      8.3.3.2.4. By Source
      8.3.3.2.5. By Application
      8.3.3.2.6. By End User
  8.3.4. Spain Cell Therapy Manufacturing Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Therapy
      8.3.4.2.2. By Source of Cell
      8.3.4.2.3. By Scale of Operation
      8.3.4.2.4. By Source
      8.3.4.2.5. By Application
      8.3.4.2.6. By End User
  8.3.5. Italy Cell Therapy Manufacturing Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Therapy
      8.3.5.2.2. By Source of Cell
      8.3.5.2.3. By Scale of Operation
      8.3.5.2.4. By Source
      8.3.5.2.5. By Application
      8.3.5.2.6. By End User

9. ASIA-PACIFIC CELL THERAPY MANUFACTURING MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Therapy
  9.2.2. By Source of Cell
  9.2.3. By Scale of Operation
  9.2.4. By Source
  9.2.5. By Application
  9.2.6. By End User
  9.2.7. By Country
9.3. Asia-Pacific: Country Analysis
  9.3.1. China Cell Therapy Manufacturing Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Therapy
      9.3.1.2.2. By Source of Cell
      9.3.1.2.3. By Scale of Operation
      9.3.1.2.4. By Source
      9.3.1.2.5. By Application
      9.3.1.2.6. By End User
  9.3.2. Japan Cell Therapy Manufacturing Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Therapy
      9.3.2.2.2. By Source of Cell
      9.3.2.2.3. By Scale of Operation
      9.3.2.2.4. By Source
      9.3.2.2.5. By Application
      9.3.2.2.6. By End User
  9.3.3. South Korea Cell Therapy Manufacturing Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Therapy
      9.3.3.2.2. By Source of Cell
      9.3.3.2.3. By Scale of Operation
      9.3.3.2.4. By Source
      9.3.3.2.5. By Application
      9.3.3.2.6. By End User
  9.3.4. Australia Cell Therapy Manufacturing Market Outlook
    9.3.4.1. Market Size & Forecast
      9.3.4.1.1. By Value
    9.3.4.2. Market Share & Forecast
      9.3.4.2.1. By Therapy
      9.3.4.2.2. By Source of Cell
      9.3.4.2.3. By Scale of Operation
      9.3.4.2.4. By Source
      9.3.4.2.5. By Application
      9.3.4.2.6. By End User
  9.3.5. India Cell Therapy Manufacturing Market Outlook
    9.3.5.1. Market Size & Forecast
      9.3.5.1.1. By Value
    9.3.5.2. Market Share & Forecast
      9.3.5.2.1. By Therapy
      9.3.5.2.2. By Source of Cell
      9.3.5.2.3. By Scale of Operation
      9.3.5.2.4. By Source
      9.3.5.2.5. By Application
      9.3.5.2.6. By End User

10. SOUTH AMERICA CELL THERAPY MANUFACTURING MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Therapy
  10.2.2. By Source of Cell
  10.2.3. By Scale of Operation
  10.2.4. By Source
  10.2.5. By Application
  10.2.6. By End User
  10.2.7. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Cell Therapy Manufacturing Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Therapy
      10.3.1.2.2. By Source of Cell
      10.3.1.2.3. By Scale of Operation
      10.3.1.2.4. By Source
      10.3.1.2.5. By Application
      10.3.1.2.6. By End User
  10.3.2. Argentina Cell Therapy Manufacturing Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Therapy
      10.3.2.2.2. By Source of Cell
      10.3.2.2.3. By Scale of Operation
      10.3.2.2.4. By Source
      10.3.2.2.5. By Application
      10.3.2.2.6. By End User
  10.3.3. Colombia Cell Therapy Manufacturing Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Therapy
      10.3.3.2.2. By Source of Cell
      10.3.3.2.3. By Scale of Operation
      10.3.3.2.4. By Source
      10.3.3.2.5. By Application
      10.3.3.2.6. By End User

11. MIDDLE EAST AND AFRICA CELL THERAPY MANUFACTURING MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value
11.2. Market Share & Forecast
  11.2.1. By Therapy
  11.2.2. By Source of Cell
  11.2.3. By Scale of Operation
  11.2.4. By Source
  11.2.5. By Application
  11.2.6. By End User
  11.2.7. By Country
11.3. MEA: Country Analysis
  11.3.1. Israel Cell Therapy Manufacturing Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Therapy
      11.3.1.2.2. By Source of Cell
      11.3.1.2.3. By Scale of Operation
      11.3.1.2.4. By Source
      11.3.1.2.5. By Application
      11.3.1.2.6. By End User
  11.3.2. South Africa Cell Therapy Manufacturing Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Therapy
      11.3.2.2.2. By Source of Cell
      11.3.2.2.3. By Scale of Operation
      11.3.2.2.4. By Source
      11.3.2.2.5. By Application
      11.3.2.2.6. By End User
  11.3.3. Saudi Arabia Cell Therapy Manufacturing Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Therapy
      11.3.3.2.2. By Source of Cell
      11.3.3.2.3. By Scale of Operation
      11.3.3.2.4. By Source
      11.3.3.2.5. By Application
      11.3.3.2.6. By End User
  11.3.4. UAE Cell Therapy Manufacturing Market Outlook
    11.3.4.1. Market Size & Forecast
      11.3.4.1.1. By Value
    11.3.4.2. Market Share & Forecast
      11.3.4.2.1. By Therapy
      11.3.4.2.2. By Source of Cell
      11.3.4.2.3. By Scale of Operation
      11.3.4.2.4. By Source
      11.3.4.2.5. By Application
      11.3.4.2.6. By End User

12. MARKET DYNAMICS

12.1. Drivers
12.2. Challenges

13. MARKET TRENDS & DEVELOPMENTS

14. CLINICAL TRIALS

15. PATENT ANALYSIS

16. COMPETITIVE LANDSCAPE

16.1. Competition Outlook
16.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
  16.2.1. Novartis AG
  16.2.2. F. Hoffmann La Roche AG
  16.2.3. Gilead Sciences, Inc.
  16.2.4. Thermo Fischer Scientific, Inc.
  16.2.5. Catalent, Inc.
  16.2.6. JSR Life Sciences LLC (KBI Biopharma Inc)
  16.2.7. Waisman Center (Waisman Biomanufacturing)
  16.2.8. Cell and Gene Therapy Catapult
  16.2.9. Merck KGaA
  16.2.10. Lonza Group
  16.2.11. Oxford Biomedica Plc
  16.2.12. WuXi AppTec
  16.2.13. Charles River Laboratories International Inc.
  16.2.14. Institut Merieux (ABL Inc.)
  16.2.15. BioCentriq
  16.2.16. Centre for Commercialization of Regenerative Medicine (CCRM)
  16.2.17. Fujifilm Holdings Corporation (Fujifilm Cellular Dynamics)
  16.2.18. Amgen Inc.
  16.2.19. Bluebird Bio Inc.
  16.2.20. Takeda Pharmaceutical Company Limited

17. STRATEGIC RECOMMENDATIONS

List Of Tables

LIST OF TABLES

Table 1: Number of Persons Aged 65 Years or Above by Geographic Region, 2019 and 2050
Table 2: Clinically Approved Cell Therapies
Table 3: Clinical Trial Studies on Cell Therapy Manufacturing till November 2021
Table 4: List of Some Recent Patents in Cell Therapy Manufacturing

List Of Figures

LIST OF FIGURES

Figure 1: Global Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 2: Global Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 3: Global Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 4: Global Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 5: Global Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 6: Global Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 7: Global Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 8: Global Cell Therapy Manufacturing Market Share, By Region, By Value, 2016-2026F
Figure 9: Global Cell Therapy Manufacturing Market Share, By Company, By Value, 2020
Figure 10: Global Cell Therapy Manufacturing Market Map, By Therapy, Market Size (USD Million) & Growth Rate (%), 2020
Figure 11: Global Cell Therapy Manufacturing Market Map, By Scale of Operations, Market Size (USD Million) & Growth Rate (%), 2020
Figure 12: Global Cell Therapy Manufacturing Market Map, By Source, Market Size (USD Million) & Growth Rate (%), 2020
Figure 13: Global Cell Therapy Manufacturing Market Map, By Application, Market Size (USD Million) & Growth Rate (%), 2020
Figure 14: Global Cell Therapy Manufacturing Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2020
Figure 15: North America Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 16: North America Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 17: North America Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 18: North America Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 19: North America Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 20: North America Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 21: North America Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 22: North America Cell Therapy Manufacturing Market Share, By Country, By Value, 2016-2026F
Figure 23: United States Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 24: United States Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 25: United States Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 26: United States Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 27: United States Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 28: United States Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 29: United States Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 30: Canada Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 31: Canada Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 32: Canada Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 33: Canada Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 34: Canada Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 35: Canada Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 36: Canada Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 37: Mexico Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 38: Mexico Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 39: Mexico Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 40: Mexico Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 41: Mexico Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 42: Mexico Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 43: Mexico Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 44: Europe Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 45: Europe Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 46: Europe Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 47: Europe Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 48: Europe Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 49: Europe Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 50: Europe Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 51: Europe Cell Therapy Manufacturing Market Share, By Country, By Value, 2016-2026F
Figure 52: Germany Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 53: Germany Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 54: Germany Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 55: Germany Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 56: Germany Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 57: Germany Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 58: Germany Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 59: France Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 60: France Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 61: France Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 62: France Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 63: France Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 64: France Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 65: France Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 66: United Kingdom Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 67: United Kingdom Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 68: United Kingdom Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 69: United Kingdom Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 70: United Kingdom Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 71: United Kingdom Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 72: United Kingdom Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 73: Spain Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 74: Spain Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 75: Spain Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 76: Spain Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 77: Spain Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 78: Spain Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 79: Spain Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 80: Italy Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 81: Italy Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 82: Italy Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 83: Italy Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 84: Italy Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 85: Italy Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 86: Italy Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 87: Asia Pacific Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 88: Asia Pacific Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 89: Asia Pacific Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 90: Asia Pacific Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 91: Asia Pacific Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 92: Asia Pacific Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 93: Asia Pacific Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 94: Asia Pacific Cell Therapy Manufacturing Market Share, By Country, By Value, 2016-2026F
Figure 95: China Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 96: China Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 97: China Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 98: China Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 99: China Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 100: China Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 101: China Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 102: Japan Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 103: Japan Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 104: Japan Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 105: Japan Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 106: Japan Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 107: Japan Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 108: Japan Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 109: South Korea Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 110: South Korea Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 111: South Korea Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 112: South Korea Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 113: South Korea Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 114: South Korea Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 115: South Korea Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 116: Australia Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 117: Australia Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 118: Australia Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 119: Australia Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 120: Australia Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 121: Australia Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 122: Australia Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 123: India Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 124: India Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 125: India Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 126: India Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 127: India Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 128: India Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 129: India Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 130: South America Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 131: South America Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 132: South America Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 133: South America Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 134: South America Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 135: South America Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 136: South America Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 137: South America Cell Therapy Manufacturing Market Share, By Country, By Value, 2016-2026F
Figure 138: Brazil Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 139: Brazil Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 140: Brazil Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 141: Brazil Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 142: Brazil Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 143: Brazil Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 144: Brazil Cell Therapy Manufacturing Market Share, By End User, By Value, 2016-2026F
Figure 145: Argentina Cell Therapy Manufacturing Market Size, By Value (USD Million), 2016-2026F
Figure 146: Argentina Cell Therapy Manufacturing Market Share, By Therapy, By Value, 2016-2026F
Figure 147: Argentina Cell Therapy Manufacturing Market Share, By Source of Cell, By Value, 2016-2026F
Figure 148: Argentina Cell Therapy Manufacturing Market Share, By Scale of Operation, By Value, 2016-2026F
Figure 149: Argentina Cell Therapy Manufacturing Market Share, By Source, By Value, 2016-2026F
Figure 150: Argentina Cell Therapy Manufacturing Market Share, By Application, By Value, 2016-2026F
Figure 151: Argentin